Navigation Links
Alexander R. Giaquinto, Ph.D., Joins Regado Biosciences as Senior Vice President of Regulatory Affairs and Quality Assurance

BASKING RIDGE, N.J. and DURHAM, N.C., Nov. 11 /PRNewswire/ -- Regado Biosciences, Inc., today announced the appointment of Alexander R. Giaquinto, Ph.D., to the newly created position of Senior Vice President of Regulatory Affairs and Quality Assurance, effective immediately. Dr. Giaquinto brings to Regado over 35 years of experience in the pharmaceutical industry, including 30 years at Schering-Plough where he held executive management positions in the areas of Worldwide Regulatory Affairs and Compliance.

In his new position, Dr. Giaquinto will report to Dr. David J. Mazzo, Ph.D., Regado's President and Chief Executive Officer, and will be based in the Company's recently established office in Basking Ridge, New Jersey. The Company's locations in both Basking Ridge and Durham, North Carolina will have members of the executive management team and development staff.

Dr. Mazzo stated, "We are tremendously pleased to welcome someone of Dr. Giaquinto's vast experience to Regado's management team. His long-standing regulatory expertise will be essential as the Company further advances its lead therapeutic candidate, the REG1 Anticoagulation System, into late-stage clinical development." Regado recently announced completion of enrollment in the Company's Phase IIa clinical study (REVERSAL-PCI) in patients undergoing elective percutaneous coronary intervention.

Dr. Giaquinto attained the level of Senior Vice President, Worldwide Regulatory Affairs, as well as being named to a special post reporting directly to the CEO overseeing Global Compliance at Schering-Plough. These experiences, coupled with that gained as the U.S. Industry Representative of the Steering Committee of the International Conference on Harmonization (ICH), has allowed him to acquire a unique understanding of national and international regulatory processes, including regulatory submissions, reviews and approvals. At Schering-Plough, Dr. Giaquinto was instrumental in establishing the development and regulatory strategies for the approvals of 74 New Drug Applications (NDAs) and Supplements, nine Biologic License Applications (BLAs) and 28 Abbreviated NDAs.

Dr. Giaquinto currently is a Director of SemBioSys Genetics, Biothera, and PQRI. He is also a member of the Advisory Boards of Avaan Therapeutics, Allozyne Inc., Sagamore Capital and EndoCeutics, and served on, as well as chaired, the Regulatory Affairs Coordinating Committee of the Pharmaceutical Research and Manufacturers of America (PhRMA). Dr. Giaquinto participates in a number of charitable activities, including as Director on the Board of Trustees of the Children's Specialized Hospital and Chairman of the Board for Children's Specialized Hospital Foundation, both in Mountainside, NJ, and Chairman of the Board of Caldwell College in New Jersey. Dr. Giaquinto earned a Bachelor of Science in Pharmacy from St. John's University and a Ph.D. in Pharmaceutics from the University of Connecticut.

About Regado Biosciences

Regado Biosciences is pioneering a new therapeutic field with the creation and development of two-component drug systems, comprising an aptamer therapeutic that can be controlled directly by its specific and matched reversal agent. Regado's technology is designed to give physicians the ability to directly control and titrate each system's therapeutic effect. Enhanced control and flexibility allow physicians to meet the individual needs of patients independent of the setting. Regado is focusing its discovery and development efforts on acute care injectable antithrombotics, a multi-billion dollar market in need of therapeutics with improved safety profiles and a greater degree of therapeutic control.

Current investors in Regado include Domain (Princeton, NJ), Quaker BioVentures (Philadelphia, PA), Aurora Funds (Durham, NC) and Caxton Advantage Life Sciences Fund (New York, NY), as well as individual investors, including Robert Kierlin.

SOURCE Regado Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Alexander M. Cutler Nominated for Election to DuPont Board of Directors
2. New Alexander, the Elephant Who Couldnt Eat Peanuts DVDs Help Children With Food Allergies
3. Human Genome Sciences Appoints John L. Lamattina, Ph.D., to Its Board of Directors
4. Conatus Pharmaceuticals Appoints Anthony W. Fox, MD, Ph.D., as Chief Medical Officer
5. ChemoCentryx Appoints Edward E. Penhoet, Ph.D., to Board of Directors
6. BioSeek Appoints Michael C. Venuti, Ph.D., Chief Executive Officer
7. Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery
8. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
9. Trust for Americas Health Joins GAO in Calling for Next Administration to Focus on Urgent Public Health Issues as Top Priorities
10. Diabetes Dad Tom Karlya Rejoins Diabetes Research Institute Foundation
11. Groseth Rejoins EMSI to Lead Healthcare Services Sales
Post Your Comments:
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)...  In a startling report released today, National Safety Council ... a comprehensive, proven plan to eliminate prescription opioid overdoses. ... states are tackling the worst drug crisis in recorded U.S. history, ... Kentucky , New Mexico , ... the 28 failing states, three – Michigan , ...
Breaking Medicine Technology: